331 related articles for article (PubMed ID: 24076548)
1. Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.
Shu Z; Heimfeld S; Gao D
Bone Marrow Transplant; 2014 Apr; 49(4):469-76. PubMed ID: 24076548
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing.
Calmels B; Houzé P; Hengesse JC; Ducrot T; Malenfant C; Chabannon C
Bone Marrow Transplant; 2003 May; 31(9):823-8. PubMed ID: 12732892
[TBL] [Abstract][Full Text] [Related]
3. An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion.
Sánchez-Salinas A; Cabañas-Perianes V; Blanquer M; Majado MJ; Insausti CL; Monserrat J; Sánchez-Ibáñez MV; Menchón P; García-Hernández A; Gómez-Espuch J; Morales A; Moraleda JM
Transfusion; 2012 Nov; 52(11):2382-6. PubMed ID: 22404870
[TBL] [Abstract][Full Text] [Related]
4. Washing transplants with Sepax 2 reduces the incidence of side effects associated with autologous transplantation and increases patients' comfort.
Huvarová L; Kořístek Z; Jelínek T; Černá L; Smejkalová J; Navrátil M; Grebeníček L; Tvrdá I; Michalíková M; Hájek R
Transfusion; 2021 Aug; 61(8):2430-2438. PubMed ID: 34197635
[TBL] [Abstract][Full Text] [Related]
5. The value of the post-thaw CD34+ count with and without DMSO removal in the setting of autologous stem cell transplantation.
Rohner N; Passweg JR; Tsakiris DA; Halter JP; Heim D; Buser AS; Infanti L; Holbro A
Transfusion; 2019 Mar; 59(3):1052-1060. PubMed ID: 30556582
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl sulfoxide-free cryopreservation solutions for hematopoietic stem cell grafts.
Kaushal R; Jahan S; McGregor C; Pineault N
Cytotherapy; 2022 Mar; 24(3):272-281. PubMed ID: 34654640
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.
Horacek JM; Jebavy L; Jakl M; Zak P; Mericka P; Maly J
Exp Oncol; 2009 Jun; 31(2):121-2. PubMed ID: 19550404
[TBL] [Abstract][Full Text] [Related]
9. Impact of lower concentrations of dimethyl sulfoxide on cryopreservation of autologous hematopoietic stem cells: a systematic review and meta-analysis of controlled clinical studies.
Bennett B; Hanotaux J; Pasala AR; Hasan T; Hassan D; Shor R; Allan DS; Maganti HB
Cytotherapy; 2024 May; 26(5):482-489. PubMed ID: 38416086
[TBL] [Abstract][Full Text] [Related]
10. Adverse events of cryopreserved hematopoietic stem cell infusions in adults: a single-center observational study.
Otrock ZK; Sempek DS; Carey S; Grossman BJ
Transfusion; 2017 Jun; 57(6):1522-1526. PubMed ID: 28301051
[TBL] [Abstract][Full Text] [Related]
11. Ischemic stroke associated with the infusion of DMSO-cryopreserved auto-PBSCs.
González-López TJ; Sánchez-Guijo FM; Ortín A; Crusoe E; Cordoba I; Corral M; Vazquez L; Caballero MD
Bone Marrow Transplant; 2011 Jul; 46(7):1035-6. PubMed ID: 20956954
[No Abstract] [Full Text] [Related]
12. Automatic washing of thawed haematopoietic progenitor cell grafts: a preclinical evaluation.
Abonnenc M; Pesse B; Tissot JD; Barelli S; Lion N
Vox Sang; 2017 May; 112(4):367-378. PubMed ID: 28337763
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.
Ikeda K; Ohto H; Yamada-Fujiwara M; Okuyama Y; Fujiwara SI; Muroi K; Mori T; Kasama K; Kanamori H; Iseki T; Nagamura-Inoue T; Kameda K; Kanda J; Nagai K; Fujii N; Ashida T; Hirose A; Takahashi T; Minakawa K; Tanosaki R
Transfusion; 2020 May; 60(5):1015-1023. PubMed ID: 32306410
[TBL] [Abstract][Full Text] [Related]
14. Patients experienced serious adverse reactions within one hour of hematopoietic stem-cell infusion.
Meric N; Parmaksız A; Gulbas Z
Transfus Clin Biol; 2023 Feb; 30(1):82-86. PubMed ID: 35987476
[TBL] [Abstract][Full Text] [Related]
15. Study of a new device for washing and concentrating cryopreserved hematopoietic stem cells and mononuclear cells: a single center experience.
Santurette CC; Charron M; Bouyer S; Houzé P; Binninger S; Lavergne A; Mercier M; Giraud C
Cytotherapy; 2022 Jan; 24(1):86-92. PubMed ID: 34690062
[TBL] [Abstract][Full Text] [Related]
16. Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide.
Cox MA; Kastrup J; Hrubiško M
Cell Tissue Bank; 2012 Jun; 13(2):203-15. PubMed ID: 21394484
[TBL] [Abstract][Full Text] [Related]
17. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
Morris C; de Wreede L; Scholten M; Brand R; van Biezen A; Sureda A; Dickmeiss E; Trneny M; Apperley J; Chiusolo P; van Imhoff GW; Lenhoff S; Martinelli G; Hentrich M; Pabst T; Onida F; Quinn M; Kroger N; de Witte T; Ruutu T;
Transfusion; 2014 Oct; 54(10):2514-22. PubMed ID: 24964911
[TBL] [Abstract][Full Text] [Related]
18. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
[TBL] [Abstract][Full Text] [Related]
19. Pentaisomaltose, an Alternative to DMSO. Engraftment of Cryopreserved Human CD34
Svalgaard JD; Talkhoncheh MS; Haastrup EK; Munthe-Fog L; Clausen C; Hansen MB; Andersen P; Gørløv JS; Larsson J; Fischer-Nielsen A
Cell Transplant; 2018 Sep; 27(9):1407-1412. PubMed ID: 30056762
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate.
Lemarie C; Calmels B; Malenfant C; Arneodo V; Blaise D; Viret F; Bouabdallah R; Ladaique P; Viens P; Chabannon C
Transfusion; 2005 May; 45(5):737-42. PubMed ID: 15847663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
